Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

1.29

Margin Of Safety %

2

Put/Call OI Ratio

0.83

EPS Next Q Diff

0.01

EPS Last/This Y

0.47

EPS This/Next Y

0.42

Price

102.7

Target Price

125.7

Analyst Recom

1.28

Performance Q

4.21

Relative Volume

1.48

Beta

0.63

Ticker: BSX




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-08-15BSX103.180.820.83214989
2025-08-18BSX103.070.700.41147178
2025-08-19BSX103.760.690.36153405
2025-08-20BSX106.030.701.12152979
2025-08-21BSX105.190.701.12153802
2025-08-22BSX106.150.711.09156977
2025-08-25BSX105.10.700.49152587
2025-08-26BSX106.450.700.26153303
2025-08-27BSX105.840.680.41158861
2025-08-28BSX105.750.680.65159136
2025-08-29BSX105.550.680.43160408
2025-09-02BSX106.650.710.61159051
2025-09-03BSX107.520.716.65161747
2025-09-04BSX107.310.810.43172396
2025-09-05BSX107.210.810.29174161
2025-09-08BSX108.150.820.39171845
2025-09-09BSX108.110.820.86172901
2025-09-10BSX105.230.830.10192344
2025-09-11BSX104.340.770.18206013
2025-09-12BSX102.730.830.43202930
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-08-15BSX103.1613.32155.02.98
2025-08-18BSX103.0313.32197.02.98
2025-08-19BSX103.7513.32239.02.98
2025-08-20BSX106.0413.32317.62.98
2025-08-21BSX105.2013.32162.62.98
2025-08-22BSX106.1313.32249.12.98
2025-08-25BSX105.1413.32153.92.98
2025-08-26BSX106.3913.32266.72.98
2025-08-27BSX105.8513.32177.82.98
2025-08-28BSX105.7413.32197.72.98
2025-08-29BSX105.5513.32194.22.98
2025-09-02BSX106.6413.32259.72.98
2025-09-03BSX107.5313.32815.82.98
2025-09-04BSX107.3113.32758.12.98
2025-09-05BSX107.2213.32766.02.98
2025-09-08BSX108.1413.32818.52.98
2025-09-09BSX108.1313.32766.02.98
2025-09-10BSX105.2513.22619.92.98
2025-09-11BSX104.3413.22721.72.98
2025-09-12BSX102.7013.22680.42.98
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-08-15BSX-9.010.691.10
2025-08-18BSX-8.87-0.991.10
2025-08-19BSX-8.47-0.991.10
2025-08-20BSX-7.62-0.991.10
2025-08-21BSX-7.62-0.991.10
2025-08-22BSX-7.57-0.991.10
2025-08-25BSX-7.450.641.10
2025-08-26BSX-7.380.641.10
2025-08-27BSX-7.380.641.26
2025-08-28BSX-7.380.641.26
2025-08-29BSX-7.380.641.26
2025-09-02BSX-7.380.681.26
2025-09-03BSX-7.750.681.26
2025-09-04BSX-7.750.681.26
2025-09-05BSX-7.750.681.26
2025-09-08BSX-7.680.731.26
2025-09-09BSX-7.680.731.26
2025-09-10BSX-7.680.731.26
2025-09-11BSX-7.680.731.29
2025-09-12BSX-7.680.731.29
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.75

Avg. EPS Est. Current Quarter

0.71

Avg. EPS Est. Next Quarter

0.76

Insider Transactions

-7.68

Institutional Transactions

0.73

Beta

0.63

Average Sales Estimate Current Quarter

4962

Average Sales Estimate Next Quarter

5169

Fair Value

104.27

Quality Score

88

Growth Score

99

Sentiment Score

78

Actual DrawDown %

6.2

Max Drawdown 5-Year %

-25.2

Target Price

125.7

P/E

61.13

Forward P/E

30.19

PEG

4.02

P/S

8.23

P/B

6.78

P/Free Cash Flow

43.67

EPS

1.68

Average EPS Est. Cur. Y​

2.98

EPS Next Y. (Est.)

3.4

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

13.55

Relative Volume

1.48

Return on Equity vs Sector %

-13.7

Return on Equity vs Industry %

-7.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

2680.4
Boston Scientific Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 53000
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
stock quote shares BSX – Boston Scientific Corporation Stock Price stock today
news today BSX – Boston Scientific Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BSX – Boston Scientific Corporation yahoo finance google finance
stock history BSX – Boston Scientific Corporation invest stock market
stock prices BSX premarket after hours
ticker BSX fair value insiders trading